Delivery Order SPE2DB24D2101-SPE2DB25FKLWW

Award Date 7/1/25
Potential Completion Date 7/23/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Privigen 10% vial, a 200 mL intravenous immunoglobulin product, with a ceiling value of $6,139.50 and a period of performance through May 21, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $18,418.50 Firm Fixed Price Delivery Order contract is for the supply of PRIVIGEN 10% vial 200ML, a specialty pharmaceutical product. The contract has an ultimate completion date of May 2, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $4,911.60, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product. The contract is a firm fixed-price agreement with a completion date of May 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PRIVIGEN 10% VIAL 200ML. The $12,279.00 firm fixed-price contract has a completion date of July 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIVIGEN 10% VIAL 200ML, a medical product, with a total ceiling value of $6,139.50. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate completion date of June 17, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,911.60 firm fixed-price delivery order is for the provision of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2025 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PRIVIGEN 10% VIAL 200ML. The contract is a Firm Fixed Price arrangement with a ceiling value of $12,279.00 and a period of performance through July 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product, with a ceiling value of $7,367.40 and a performance period ending on July 9, 2025. The contract is not set aside and was awarded on June 16, 2025. Amerisourcebergen Drug Corp is a for-profit organization...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product. The contract is a Firm Fixed Price type and has a ceiling value of $6,139.50. The contract is not set aside and is open to competition. The place of performance is Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $25,636.05 firm fixed-price contract is for the supply of Privigen 10% Vial 200ML, a pharmaceutical product, with a period of performance through August 17, 2023. The award is not associated with a set-aside program. This delivery order is part of a larger $499,999,999 indefinite delivery...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKLWW
    Delivery Order

This is a $12,279.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product Privigen 10% Vial 200mL, with a performance period ending on July 23, 2025. This award is not designated as a set-aside contract.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/30/25, 9:54 AM